What is NDC 65862-163?

65862-163 is the product NDC for Quinapril Hydrochloride/Hydrochlorothiazide, Quinapril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Quinapril Hydrochloride/Hydrochlorothiazide.

What is the active ingredient?

Quinapril hydrochloride, Hydrochlorothiazide.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Quinapril Hydrochloride/Hydrochlorothiazide?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 65862-163

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-163Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0163Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-163-90	6586201639065862016390	90 TABLET, FILM COATED in 1 BOTTLE (65862-163-90)Marketed from Aug 24, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quinapril Hydrochloride/Hydrochlorothiazide
Generic name (nonproprietary): quinapril hydrochloride/hydrochlorothiazide
Active ingredients: Quinapril hydrochloride — 20 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078450
Marketing start: Aug 24, 2007
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 65862-163_5842ecc2-874a-481b-8997-afa9d862dc5dSPL ID 5842ecc2-874a-481b-8997-afa9d862dc5dSPL set ID 50a58159-9572-4445-9859-b392632597daRxCUI 310796, 310797, 310809UNII 0J48LPH2TH, 33067B3N2MUPC 0365862161901
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862016390 followed by a unit qualifier and the quantity

Package 65862-0163-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 28, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Quinapril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-163

What is NDC 65862-163?: 65862-163 is the product NDC for Quinapril Hydrochloride/Hydrochlorothiazide, Quinapril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Quinapril Hydrochloride/Hydrochlorothiazide.
What is the active ingredient?: Quinapril hydrochloride, Hydrochlorothiazide.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Quinapril Hydrochloride/Hydrochlorothiazide?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Quinapril Hydrochloride/Hydrochlorothiazide NDC 65862-163